The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ($CVS) and Cigna ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

The Big Three PBMs have largely criticized the FTC report. A spokesperson for CVS Health argued that the FTC has drawn broad conclusions from “cherry-picked” specialty generic outliers in both ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth ... organ transplants and other conditions and procedures, the FTC said. The report demonstrates how pharmacy benefit ...

Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their ...

CVS Health, UnitedHealth Group and Cigna share prices dipped midday after the FTC released its report, but each company rebounded and was up slightly when the New York Stock Exchange closed Tuesday.

Evercore ISI raised the firm’s price target on CVS Health (CVS) to $65 from $60 and keeps an Outperform rating on the shares. Given 2025 will ...